News
1 minute read

MBHB Partner Kevin Noonan Quoted in FiercePharma Article Entitled, "In landmark Amgen v. Sandoz ruling, biosim makers can give notice before FDA nod"

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 12, 2017 edition of FiercePharma.com in an article entitled, “In landmark Amgen v. Sandoz ruling, biosim makers can give notice before FDA nod.” Biosim makers scored a big win Monday as the Supreme Court ruled with Sandoz in a much-watched legal dispute with Amgen. View the article